Barrett's oesophagus: epidemiology, cancer risk and implications for management.
about
Acetic acid chromoendoscopy: Improving neoplasia detection in Barrett's esophagusAdvances in the endoscopic diagnosis and treatment of Barrett's neoplasiaEpidemiology of Barrett's Esophagus and Esophageal AdenocarcinomaThe epidemiology, diagnosis, and treatment of Barrett's carcinomaEmerging optical methods for surveillance of Barrett's oesophagusMetabolic syndrome is associated with increased risk of Barrett esophagus: A meta-analysis.Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directionsMechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.Epigenetics in the Pathogenesis of Esophageal AdenocarcinomaAndrogens and esophageal cancer: What do we know?Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice.Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewHistopathology in barrett esophagus and barrett esophagus-related dysplasia.The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression.Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum.Definition of Barrett's esophagus dysplasia: are we speaking the same language?The past 10 years of gastroenterology and hepatology-reflections and predictions.The Effect of Campylobacter concisus on Expression of IL-18, TNF-α and p53 in Barrett's Cell Lines.Esophageal development and epithelial homeostasis.Barrett's oesophagus: how should we manage it?Risk factors for Barrett's esophagus: a scoping review.Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.Upper Gastrointestinal Endoscopy prior to Bariatric Surgery-Mandatory or Expendable? An Analysis of 801 Cases.What Makes an Expert Barrett's Histopathologist?Bile acids but not acidic acids induce Barrett's esophagus.Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial.Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells.Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects.In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction.Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus.Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.Development of a risk prediction model for Barrett's esophagus in an Australian population.A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
P2860
Q26739034-5C2D3615-F489-46A4-9B5E-C01E6A88E89EQ26766113-E20CC3F7-C65D-4D95-B7A4-8E290CAF9299Q26825742-C6917B5D-824E-4146-B774-63484E8B30C2Q27027149-18F92C01-D89F-4E85-8408-4BD1E4D255EDQ28082600-41688CCA-6C48-421C-82DA-CF8A88086729Q30248613-DB2DE455-77F2-4F23-BDD0-99879247DA58Q34624586-15ADD2E9-AAD8-48B3-957A-0B9163764D69Q35086878-14AC5426-3DF1-44A6-8226-AC6B6D216BC7Q35162477-D4BF6F4B-29DA-46BE-B237-809E5F153B97Q35598456-8DE12DB9-5035-465E-AF37-9F8EB5973E47Q35651459-BD2F5E95-D83A-4CCC-8D63-A8300A146FF8Q36200666-7CD2E228-1006-4D58-BD58-FD0BC0666B6BQ37018314-DF5652B0-1041-45C2-9B6A-DBFCBD46A67FQ37190164-0C25FCC1-7E60-4CBA-B5A1-1B59B65D8223Q37542809-555E7DB4-6E48-4FB7-ADB5-F541BAFA7A33Q38191222-81F5A659-8BCF-4497-BE7B-71108EC6A2FCQ38212001-7843EF16-81C5-4E9E-85EE-C054643C5610Q38215075-4E362EB1-2257-4C94-9825-3EB96C53CF0CQ38228588-0DA2C6CD-445B-48F9-9C34-3C2CE2B575EDQ38257761-E4E1B484-9C0C-4DC5-88E4-2C87C224FA8AQ38274765-4B30977B-54ED-4D90-9145-0D02A463689CQ38542183-D09EA185-88CD-4C4D-9AE7-ADBF3FB02296Q38608994-683C4818-9201-4A42-8CE2-2414D67978EEQ38723616-4E96EE5F-9A8D-4662-9584-90B4B3370A07Q38904116-62208C2D-DB21-4FCB-90FB-8651D0992387Q38938087-C5FC3C4B-4E98-44FD-8D30-4BAE41DBA3D6Q38940516-F80EEFB0-85CB-4C56-8A7B-1350A0043E50Q39614242-5D1ED64F-F53F-4415-9AEB-0735377A9E67Q40795341-ECEC0FC5-5F93-4548-95D5-AAD2B71C3663Q41231837-1B8CB73B-1535-44D0-A83A-DE55F91B446DQ42705165-E7559F8F-C2E0-4ACD-8A5B-8CB844155C76Q47271716-CBD8905C-DBEC-4F8B-92E0-4BB7508B5F38Q47398017-9E18ED07-0387-4473-B50A-5A710D02B8A9Q49195031-D3623D3E-B2B9-4E58-9B4D-3AF3F1B32FF2Q49875087-63AF68FE-CFA2-451F-92AF-482DDE20E36BQ50124161-D09A5641-129E-4256-B539-A9128B7F235EQ50205203-28D06C33-915B-4214-8DE1-AF54EEBEEA57Q50205227-E434E18B-D496-4ACB-A230-AE4EF92A8B3AQ52867602-605E586E-570D-4F5A-9A15-C1C0E050F47AQ58702858-96AE2EE2-4773-4428-9EB9-0A40EA0C915C
P2860
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@ast
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@en
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@nl
type
label
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@ast
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@en
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@nl
prefLabel
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@ast
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@en
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@nl
P2093
P2860
P1433
P1476
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
@en
P2093
Mark van Blankenstein
Pieter Jan F de Jonge
William M Grady
P2860
P304
P356
10.1136/GUTJNL-2013-305490
P407
P577
2013-10-03T00:00:00Z